AUGUSTIN LIN: Open Payments
NPI 1003991688 · CHINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 17 payments from 7 companies in 2025. Trend: 2023 $736 · 2024 $716 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $293 |
| Novo Nordisk Inc | 1 | $125 |
| Lilly USA, LLC | 1 | $72 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| PFIZER INC. | 1 | $28 |
| Amgen Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: AIRSUPRA, BREZTRI, Ozempic, MOUNJARO, TRELEGY ELLIPTA, PREVNAR 20, OTEZLA, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
